April 25, 2017 6:09 AM ET


Company Overview of Garnet Biotherapeutics, Inc.

Key Executives for Garnet Biotherapeutics, Inc.

NameBoard RelationshipsTitleAge
Geraldine A. Henwood Ph.D.24 RelationshipsChief Executive Officer and Director64
Scott A. Bailey No RelationshipsChief Financial Officer--
Jan D. Wallace M.D.10 RelationshipsSenior Vice President of Clinical & Regulatory Affairs75

Garnet Biotherapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Geraldine A. Henwood Ph.D. 24 RelationshipsRecro Pharma, Inc.64
Gary J. Kurtzman M.D. 142 RelationshipsSafeguard Scientifics, Inc.61
James P. O'Connell 10 RelationshipsGarnet Biotherapeutics, Inc.--
Wayne B. Weisman J.D. 44 RelationshipsSCP Vitalife60
View All Board Members

Garnet Biotherapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Total Value of Options
Compensation as of Fiscal Year
Garnet Biotherapeutics, Inc. CEO Compensation
Industry Average


Stewart White to Step Down as Chief Scientific Officer and Leave the Board of Collagen Solutions plc
April 24, 2017 6:00 AM ET
BioPorto A/S Elects Kirsten Drejer as New Board Member
April 21, 2017 2:52 PM ET
Aeglea Biotherapeutics, Inc. Announces Executive Changes
April 21, 2017 12:00 PM ET
Anavex Life Sciences Corp. Approves to Elect Christopher Missling as Director
April 21, 2017 10:09 AM ET
Rasna Therapeutics, Inc. Announces Management Changes
April 20, 2017 8:30 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Garnet Biotherapeutics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.